The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
Open accessAbstract
Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on expert opinions, but they have not been validated. Here we present the validated EuroFlow 8-color antibody panels for immunophenotyping of hematological malignancies. The single-tube screening panels and multi-tube classification panels fit into the EuroFlow diagnostic algorithm with entries defined by clinical and laboratory parameters. The panels were constructed in 2-7 sequential design-evaluation-redesign rounds, using novel Infinicyt software tools for multivariate data analysis. Two groups of markers are combined in each 8-color tube: (i) backbone markers to identify distinct cell populations in a sample, and (ii) markers for characterization of specific cell populations. In multi-tube panels, the backbone markers were optimally placed at the same fluorochrome position in every tube, to provide identical multidimensional localization of the target cell population(s). The characterization markers were positioned according to the diagnostic utility of the combined markers. Each proposed antibody combination was tested against reference databases of normal and malignant cells from healthy subjects and WHO-based disease entities, respectively. The EuroFlow studies resulted in validated and flexible 8-color antibody panels for multidimensional identification and characterization of normal and aberrant cells, optimally suited for immunophenotypic screening and classification of hematological malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
Hallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M. J., Montserrat, E., Rai, K. R., et al. (2008) · Blood · doi:10.1182/blood-2007-06-093906 · Cited by 3,787
WHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
van Dongen, J. J. M., Langerak, A. W., Brüggemann, M., Evans, P. A. S., Hummel, M., Lavender, F. L., Delabesse, E., Davi, F., Schuuring, E., García-Sanz, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403202 · Cited by 3,043
Self-citationThe Non-Hodgkin's Lymphoma Classification Project (1997) · Blood · doi:10.1182/blood.v89.11.3909 · Cited by 2,461
Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues
Jaffe, E. S. (2003) · Cited by 2,141
Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Ferrando, A. A., Neuberg, D. S., Staunton, J., Loh, M. L., Huard, C., Raimondi, S. C., Behm, F. G., Pui, C.-H., Downing, J. R., Gilliland, D. G., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00018-1 · Cited by 1,131
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Coustan-Smith, E., Mullighan, C. G., Onciu, M., Behm, F. G., Raimondi, S. C., Pei, D., Cheng, C., Su, X., Rubnitz, J. E., Basso, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70314-0 · Cited by 1,019
Pathology and genetics: Tumours of haematopoietic and lymphoid tissues
Vyas, P. (2001) · The Lancet Oncology · Cited by 1,007
Mechanisms of B-cell lymphoma pathogenesis
Küppers, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1589 · Cited by 965
Savage, K. J., Harris, N. L., Vose, J. M., Ullrich, F., Jaffe, E. S., Connors, J. M., Rimsza, L., Pileri, S. A., Chhanabhai, M., Gascoyne, R. D., et al. (2008) · Blood · doi:10.1182/blood-2008-01-134270 · Cited by 863
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., Kalina, T., Flores-Montero, J., van der Velden, V. H. J., Martin-Ayuso, M., Böttcher, S., Ritgen, M., Almeida, J., Lhermitte, L., Asnafi, V, et al. (2012) · Leukemia · doi:10.1038/leu.2012.122 · Cited by 783
Self-citationImmunologic classification of leukemia and lymphoma.
Foon, K. A., & Todd, R. F. (1986) · PubMed · doi:10.1182/blood.v68.1.1.1 · Cited by 736
Flow cytometric immunophenotyping for hematologic neoplasms
Craig, F. E., & Foon, K. A. (2008) · Blood · doi:10.1182/blood-2007-11-120535 · Cited by 672
Jaffe, E. S. (2009) · Hematology · doi:10.1182/asheducation-2009.1.523 · Cited by 632
Pérez-Persona, E., Vidriales, M.-B., Mateo, G., García-Sanz, R., Mateos, M.-V., de Coca, A. G., Galende, J., Martín-Nuñez, G., Alonso, J. M., de las Heras, N., et al. (2007) · Blood · doi:10.1182/blood-2007-05-088443 · Cited by 579
Self-citationProposals for immunological classification of acute leukemias.
van Dongen, J. J. M. (1995) · PubMed · Cited by 543
Lenz, G., & Staudt, L. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0807082 · Cited by 528
Rawstron, A. C., Orfao, A., Beksac, M., Bezdickova, L., Brooimans, R. A., Bumbea, H., Dalva, K., Fuhler, G., Gratama, J., Hose, D., et al. (2008) · Haematologica · doi:10.3324/haematol.11080 · Cited by 513
Self-citationProposals for the immunological classification of acute leukemias.
Paietta, E. M. (1995) · PubMed · Cited by 503
The earliest thymic progenitors for T cells possess myeloid lineage potential
Bell, J. J., & Bhandoola, A. (2008) · Nature · doi:10.1038/nature06840 · Cited by 460
Flow Cytometric Immunophenotypic Analysis of 306 Cases of Multiple Myeloma
Lin, P. Y., Owens, R., Tricot, G. J. K., & Wilson, C. S. (2004) · American Journal of Clinical Pathology · doi:10.1309/74r4-tb90-buwh-27jx · Cited by 454
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
Graux, C., Cools, J., Melotte, C., Quentmeier, H., Ferrando, A., Levine, R., Vermeesch, J. R., Stul, M., Dutta, B., Boeckx, N., et al. (2004) · Nature Genetics · doi:10.1038/ng1425 · Cited by 433
Molecular pathogenesis of T-cell leukaemia and lymphoma
Aifantis, I., Raetz, E., & Buonamici, S. (2008) · Nature Reviews Immunology · doi:10.1038/nri2304 · Cited by 428
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis
Freilich, R. J., Krol, G., & Deangelis, L. M. (1995) · Annals of Neurology · doi:10.1002/ana.410380111 · Cited by 412
Borowitz, M. J., Craig, F. E., DiGiuseppe, J. A., Illingworth, A. J., Rosse, W., Sutherland, D. R., Wittwer, C. T., & Richards, S. J. (2010) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.20525 · Cited by 403
Rawstron, A. C., Villamor, N., Ritgen, M., Böttcher, S., Ghia, P., Zehnder, J. L., Lozanski, G., Colomer, D., Moreno, C., Geuna, M., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404584 · Cited by 403
Self-citationImprovement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
Herrmann, A., Hoster, E., Zwingers, T., Brittinger, G., Engelhard, M., Meusers, P., Reiser, M., Forstpointner, R., Metzner, B., Peter, N., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.8435 · Cited by 399
McKenna, R. W., Washington, L. T., Aquino, D. B., Picker, L. J., & Kroft, S. H. (2001) · Blood · doi:10.1182/blood.v98.8.2498 · Cited by 394
Soulier, J., Clappier, E., Cayuela, J.-M., Regnault, A., García-Peydró, M., Dombret, H., Baruchel, A., Toribio, M.-L., & Sigaux, F. (2005) · Blood · doi:10.1182/blood-2004-10-3900 · Cited by 383
Sawadogo, D., Tolo, A., Kassi, H., Sangare, M., & Inwoley, A. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.023 · Cited by 381
van Rhenen, A., Feller, N., Kelder, A., Westra, A. H., Rombouts, E., Zweegman, S., van der Pol, M. A., Waisfisz, Q., Ossenkoppele, G. J., & Schuurhuis, G. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0468 · Cited by 375
Wells, D. A., Benesch, M., Loken, M. R., Vallejo, C., Myerson, D., Leisenring, W. M., & Deeg, H. J. (2003) · Blood · doi:10.1182/blood-2002-09-2768 · Cited by 358
Phenotypic difference of normal plasma cells from mature myeloma cells
Harada, H., Kawano, M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H., & Kuramoto, A. (1993) · Blood · doi:10.1182/blood.v81.10.2658.2658 · Cited by 355
Brüggemann, M., Schrauder, A., Raff, T., Pfeifer, H., Dworzak, M., Ottmann, O. G., Asnafi, V, Baruchel, A., Bassan, R., Benoit, Y., et al. (2010) · Leukemia · doi:10.1038/leu.2009.268 · Cited by 341
Self-citationvan Lochem, E. G., van der Velden, V. H. J., Wind, H. K., te Marvelde, J. G., Westerdaal, N. A. C., & van Dongen, J. J. M. (2004) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.20008 · Cited by 333
Self-citationDworzak, M. N., Fröschl, G., Printz, D., Mann, G., Pötschger, U., Mühlegger, N., Fritsch, G., & Gadner, H. (2002) · Blood · doi:10.1182/blood.v99.6.1952 · Cited by 325
Matutes, E., Pickl, W. F., van't Veer, M., Morilla, R., Swansbury, J., Strobl, H., Attarbaschi, A., Hopfinger, G., Ashley, S., Bene, M. C., et al. (2011) · Blood · doi:10.1182/blood-2010-10-314682 · Cited by 325
Self-citationBorkhardt, A., Cazzaniga, G., Viehmann, S., Valsecchi, M. G., Ludwig, W. D., Burci, L., Mangioni, S., Schrappe, M., Riehm, H., Lampert, F., et al. (1997) · Blood · doi:10.1182/blood.v90.2.571 · Cited by 319
Borowitz, M. J., Lynn Guenther, K., Shults, K. E., & Stelzer, G. T. (1993) · American Journal of Clinical Pathology · doi:10.1093/ajcp/100.5.534 · Cited by 313
Basso, G., Veltroni, M., Valsecchi, M. G., Dworzak, M. N., Ratei, R., Silvestri, D., Benetello, A., Buldini, B., Maglia, O., Masera, G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8934 · Cited by 284
Graux, C., Cools, J., Michaux, L., Vandenberghe, P., & Hagemeijer, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404302 · Cited by 276
Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.
Muñoz, L., Nomdedeu, J. F., López, O., Carnicer, M. J., Bellido, M., Aventin, A. M., Brunet, S., & Sierra, J. (2001) · PubMed · Cited by 269
Escribano, L., Orfao, A., Dı́az-Agustin, B., Villarrubia, J., Cerveró, C., López, A., Marcos, M. A. G., Bellas, C., Fernández-Cañadas, S., Cuevas, M., et al. (1998) · Blood · doi:10.1182/blood.v91.8.2731.2731_2731_2736 · Cited by 248
Self-citationvan de Loosdrecht, A. A., Alhan, C., Bene, M. C., Della Porta, M. G., Drager, A. M., Feuillard, J., Font, P., Germing, U., Haase, D., Homburg, C. H., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.005801 · Cited by 239
Self-citationLangerak, A. W., van den Beemd, R., Wolvers-Tettero, I. L. M., Boor, P. P. C., van Lochem, E. G., Hooijkaas, H., & van Dongen, J. J. M. (2001) · Blood · doi:10.1182/blood.v98.1.165 · Cited by 238
Self-citationLúcio, P., Parreira, A., van den Beemd, M., van Lochem, E., van Wering, E., Baars, E., Porwit-MacDonald, A., Bjorklund, E., Gaipa, G., Biondi, A., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401279 · Cited by 236
Self-citationKita, K., Nakase, K., Miwa, H., Masuya, M., Nishii, K., Morita, N., Takakura, N., Otsuji, A., Shirakawa, S., & Ueda, T. (1992) · Blood · doi:10.1182/blood.v80.2.470.470 · Cited by 234
Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia
Lacombe, F., Durrieu, F., Briais, A., Dumain, P., Belloc, F., Bascans, E., Reiffers, J., Boisseau, M., & Bernard, P. (1997) · Leukemia · doi:10.1038/sj.leu.2400847 · Cited by 231
van de Loosdrecht, A. A., Westers, T. M., Westra, A. H., Dräger, A. M., van der Velden, V. H. J., & Ossenkoppele, G. J. (2008) · Blood · doi:10.1182/blood-2007-07-098764 · Cited by 225
Self-citationBataille, R., Jégo, G., Robillard, N., Barillé‐Nion, S., Harousseau, J., Moreau, P., Amiot, M., & Pellat‐Deceunynck, C. (2006) · PubMed · Cited by 225
Bisset, L. R., Lung, T. L., Kaelin, M., Ludwig, E., & Dubs, R. W. (2004) · European Journal of Haematology · doi:10.1046/j.0902-4441.2003.00199.x · Cited by 224
Rothe, G., & Schmitz, G. (1996) · PubMed · Cited by 221
Selecting fluorochrome conjugates for maximum sensitivity
Maecker, H. T., Frey, T., Nomura, L. E., & Trotter, J. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20092 · Cited by 216
Quijano, S., López, A., Manuel Sancho, J., Panizo, C., Debén, G., Castilla, C., Antonio García-Vela, J., Salar, A., Alonso-Vence, N., González-Barca, E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7089 · Cited by 215
Self-citationMateo, G., Montalbán, M. A., Vidriales, M.-B., Lahuerta, J. J., Mateos, M. V., Gutiérrez, N., Rosiñol, L., Montejano, L., Bladé, J., Martínez, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4120 · Cited by 208
Self-citationHerling, M., Khoury, J. D., Washington, L. T., Duvic, M., Keating, M. J., & Jones, D. (2004) · Blood · doi:10.1182/blood-2004-01-0002 · Cited by 205
Cd20 (pan‐B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes
Hultin, L. E., Hausner, M. A., Hultin, P. M., & Giorgi, J. V. (1993) · Cytometry · doi:10.1002/cyto.990140212 · Cited by 204
Paiva, B., Almeida, J., Pérez‐Andrés, M., Mateo, G., López, A., Rasillo, A., Vídriales, M., López‐Berges, M., Miguel, J. F. S., & Orfao, A. (2010) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.20512 · Cited by 203
Self-citationPlasma Cell Neoplasms: A Morphologic, Cytogenetic and Immunophenotypic Approach
(2016) · Springer eBooks · doi:10.1007/978-3-319-10918-3 · Cited by 194
Antigen expression patterns reflecting genotype of acute leukemias
Hrušák, O., & Porwit-MacDonald, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402504 · Cited by 188
Flow cytometric analysis of the V? repertoire in healthy controls
van den Beemd, R., Boor, P. P. C., van Lochem, E. G., Hop, W. C. J., Langerak, A. W., Wolvers-Tettero, I. L. M., Hooijkaas, H., & van Dongen, J. J. M. (2000) · Cytometry · doi:10.1002/1097-0320(20000801)40:4<336::aid-cyto9>3.0.co;2-0 · Cited by 178
Self-citationAsnafi, V., Beldjord, K., Boulanger, E., Comba, B., Tutour, P. L., Estienne, M., Davi, F., Landman‐Parker, J., Quartier, P., Buzyn, A., et al. (2003) · Blood · doi:10.1182/blood-2002-08-2438 · Cited by 174
Self-citationEly, S. A., & Knowles, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62556-4 · Cited by 172
Chen, J.-S., Coustan-Smith, E., Suzuki, T., Neale, G. A., Mihara, K., Pui, C.-H., & Campana, D. (2001) · Blood · doi:10.1182/blood.v97.7.2115 · Cited by 170
Morice, W. G., Kurtin, P. J., Leibson, P. J., Tefferi, A., & Hanson, C. A. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04201.x · Cited by 169
Haferlach, C., Mecucci, C., Schnittger, S., Kohlmann, A., Mancini, M., Cuneo, A., Testoni, N., Rege-Cambrin, G., Santucci, A., Vignetti, M., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197871 · Cited by 167
Barrena, S., Almeida, J., Yunta, M., López, A., Fernández-Mosteirín, N., Giralt, M., Romero, M., Perdiguer, L., Delgado, M., Orfao, A., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403822 · Cited by 165
Self-citationCALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCR lineage
Asnafi, V. (2003) · Blood · doi:10.1182/blood-2002-09-2913 · Cited by 165
Self-citationProgress in understanding and managing natural killer‐cell malignancies
Oshimi, K. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06835.x · Cited by 157
Epidemiology of the plasma-cell disorders
Kyle, R. A., & Rajkumar, S. V. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2007.08.001 · Cited by 150
Escribano, L., Díaz-Agustín, B., López, A., Núñez, R., García‐Montero, A. C., Almeida, J., Prados, A., Angulo, M., Herrero, S., Órfão, A., et al. (2004) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.10072 · Cited by 148
Self-citationCytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies
van Dongen, J. J. M., Krissansen, G., Wolvers-Tettero, I. L. M., Comans-Bitter, W. M., Adriaansen, H. J., Hooijkaas, H., van Wering, E., & Terhorst, C. (1988) · Blood · doi:10.1182/blood.v71.3.603.603 · Cited by 145
Weir, E., Cowan, K., Lebeau, P., & Borowitz, M. J. (1999) · Leukemia · doi:10.1038/sj.leu.2401364 · Cited by 145
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome
Porta, M. G. D., Malcovati, L., Invernizzi, R., Travaglino, E., Pascutto, C., Maffioli, M., Gallì, A., Boggi, S., Pietra, D., Vanelli, L., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404142 · Cited by 143
Herling, M., Patel, K. A., Teitell, M. A., Konopleva, M. Y., Ravandi, F., Kobayashi, R., & Jones, D. M. (2007) · Blood · doi:10.1182/blood-2007-07-101519 · Cited by 140
Acute leukemias of ambiguous lineage
Béné, M. C., & Porwit‐MacDonald, A. (2012) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2011.08.004 · Cited by 139
CD28-mediated regulation of multiple myeloma cell proliferation and survival
Bahlis, N. J., King, A. M., Kolonias, D. S., Carlson, L. M., Liu, H. Y., Hussein, M. A., Terebelo, H. R., Byrne, G. E., Levine, B. L., Boise, L., et al. (2007) · Blood · doi:10.1182/blood-2006-03-012542 · Cited by 137
Borowitz, M. J., Bray, R. A., Gascoyne, R. D., Melnick, S. J., Parker, J. W., Picker, L. J., & Stetler‐Stevenson, M. (1997) · Cytometry · Cited by 137
Adriaansen, H. J., Boekhorst, P. T., Hagemeijer, A., et al. (1993) · Blood · doi:10.1182/blood.v81.11.3043.3043 · Cited by 133
Coustan‐Smith, E., Ribeiro, R. C., Stow, P., Zhou, Y., Pui, C., Rivera, G. K., Pedrosa, F. D. P. R., & Campana, D. (2006) · Blood · doi:10.1182/blood-2006-01-0066 · Cited by 133
Molecular pathology of primary intraocular lymphoma
Chan, C. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.02.095 · Cited by 132
Davis, B. H., Holden, J. T., Bene, M. C., et al. (2007) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20365 · Cited by 131
da Costa, E. S., Pedreira, C. E., Bárrena, S., Lécrevisse, Q., Flores-Montero, J. A., Quijano, S., Almeida, J., García-Macías, M. D. C., Böttcher, S., van Dongen, J. J. M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.160 · Cited by 131
Self-citationPAX5 Expression in Acute Leukemias
Tiacci, E., Pileri, S. A., Orleth, A., Pacini, R., Tabarrini, A., Frenguelli, F., Liso, A., Diverio, D., Lo‐Coco, F., & Falini, B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1865 · Cited by 128
Matarraz, S., López, A., Bárrena, S., Fernandez, C., Jensen, E., Flores-Montero, J. A., Bárcena, P., Rasillo, A., Sayagués, J. M., Sánchez, M. L., et al. (2008) · Leukemia · doi:10.1038/leu.2008.49 · Cited by 126
Self-citationMalcovati, L., Porta, M. G. D., Lunghi, M., Pascutto, C., Vanelli, L., Travaglino, E., Maffioli, M., BERNASCONI, P. P., Lazzarino, M., Invernizzi, R., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403680 · Cited by 125
Immunophenotypic Analysis of Peripheral T-Cell Neoplasms
Jamal, S., Picker, L. J., Aquino, D. B., McKenna, R. W., Dawson, D. B., & Kroft, S. H. (2001) · American Journal of Clinical Pathology · doi:10.1309/qf6n-vaqw-n74h-4je2 · Cited by 125
Orfao, A., Schmitz, G., Brando, B., Ruı́z-Argüelles, A., Basso, G., Braylan, R. C., Rothe, G., Lacombe, F., Lanza, F., Papa, S., et al. (1999) · PubMed · Cited by 123
Self-citationIncidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.
Bueno, C., Almeida, J., Lúcio, P., Marco, J., García, R., Pablos, J. M. D., Parreira, A., Ramos, F., Ruiz‐Cabello, F., Suárez‐Vilela, D., et al. (2004) · PubMed · Cited by 123
Self-citationGenetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia.
Keersmaecker, K. D., Marynen, P., & Cools, J. (2005) · PubMed · Cited by 112
Zambello, R., Falco, M., Chiesa, M. D., Trentin, L., Carollo, D., Castriconi, R., Cannas, G., Carlomagno, S., Cabrelle, A., Lamy, T., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3898 · Cited by 112
Scott, B. L., Wells, D. A., Loken, M. R., Myerson, D., Leisenring, W. M., & Deeg, H. J. (2008) · Blood · doi:10.1182/blood-2008-05-153700 · Cited by 111
Tabernero, M. D., Bortoluci, A., Alaejos, I., López-Berges, M. C., Rasillo, A., García‐Sánz, R., Garcia, M., Sayagués, J. M., González, M., Mateo, G., et al. (2001) · Leukemia · doi:10.1038/sj.leu.2402060 · Cited by 107
Self-citationFlow cytometry in myelodysplastic syndromes: Report from a working conference
Loken, M. R., van de Loosdrecht, A. A., Ogata, K., Órfão, A., & Wells, D. A. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.04.020 · Cited by 106
Lundell, R. B., Hartung, L., Hill, S., Perkins, S. L., & Bahler, D. W. (2005) · American Journal of Clinical Pathology · doi:10.1309/ph7x78hf4fw4prkw · Cited by 105
van Grotel, M., Meijerink, J. P. P., Beverloo, H. B., Langerak, A. W., Buys-Gladdines, J. G. C. A. M., Schneider, P., Poulsen, T. S., den Boer, M. L., Horstmann, M. A., Kamps, W. A., et al. (2006) · PubMed · Cited by 104
Self-citationPlasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
Garnache‐Ottou, F., Feuillard, J., & Saas, P. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06458.x · Cited by 104
Yu, H., Shahsafaei, A., & Dorfman, D. M. (2008) · American Journal of Clinical Pathology · doi:10.1309/ajcp62wrkerpxdrt · Cited by 104
Garnache‐Ottou, F., Chaperot, L., Biichle, S., Ferrand, C., Remy-Martin, J.-P., Deconinck, E., de Tailly, P. D., Bulabois, B., Poulet, J., Kuhlein, E., et al. (2004) · Blood · doi:10.1182/blood-2004-06-2416 · Cited by 103
Uckun, F. M., Gaynon, P. S., Sensel, M. G., Nachman, J. B., Trigg, M., Steinherz, P. G., Hutchinson, R., Bostrom, B., Sather, H. N., & Reaman, G. H. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2214 · Cited by 102
Matarraz, S., López, A., Bárrena, S., Fernández, C., Jensen, E., Flores-Montero, J. A., Rasillo, A., Sayagués, J. M., Sánchez, M. L., Bárcena, P., et al. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20513 · Cited by 99
Self-citationEpling‐Burnette, P. K., Painter, J. S., Chaurasia, P., Bai, F., Wei, S., Djeu, J. Y., & Loughran, T. P. (2004) · Blood · doi:10.1182/blood-2003-02-0400 · Cited by 97
Immunophenotyping of acute leukemias and myelodysplastic syndromes
Órfão, A., Ortuño, F. J., de Santiago, M., López, A., & Miguel, J. F. S. (2004) · Cytometry Part A · doi:10.1002/cyto.a.10104 · Cited by 97
Immunological classification of acute myeloblastic leukemias: relevance to patient outcome
Casasnovas, O., Slimane, F. K. R., Garand, R., Faure, G. C., Campos, L., Deneys, V., Bernier, M., Falkenrodt, A., Calvez, G. L., Maynadié, M., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402821 · Cited by 96
Böttcher, S., Ritgen, M., Pott, C., Brüggemann, M., Raff, T., Stilgenbauer, S., Döhner, H., Dreger, P., & Kneba, M. (2004) · Leukemia · doi:10.1038/sj.leu.2403478 · Cited by 96
Self-citationGeneration of flow cytometry data files with a potentially infinite number of dimensions
Pedreira, C. E., da Costa, E. S., Bárrena, S., Lécrevisse, Q., Almeida, J., van Dongen, J. J. M., & Órfão, A. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20608 · Cited by 93
Self-citationMolecular Genetics of Acute Lymphoblastic Leukemia
Teitell, M. A., & Pandolfi, P. P. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092227 · Cited by 93
Characterization of aberrant phenotypes in acute myeloblastic leukemia
Macedo, A., Órfão, A., Vídriales, M., López-Berges, M. C., Valverde, B., González, M., Caballero, M. D., Ramos, F., Martínez, M. D. L., Fernández‐Calvo, J., et al. (1995) · Annals of Hematology · doi:10.1007/bf01700374 · Cited by 90
Zen, L. D., Orfao, A., Cazzaniga, G., Masiero, L., Cocito, M. G., Spinelli, M., Rivolta, A., Biondi, A., Zanesco, L., & Basso, G. (2000) · Leukemia · doi:10.1038/sj.leu.2401824 · Cited by 87
Self-citationDetection of Novel CD Antigens on the Surface of Human Mast Cells and Basophils
Ghannadan, M., Hauswirth, A. W., Schernthaner, G.-H., Müller, M. R., Klepetko, W., Schatzl, G., Sperr, W. R., Bühring, H., & Valent, P. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000057747 · Cited by 81
Molecular classification of T-cell lymphomas
de Leval, L., Bisig, B., Thielen, C., Boniver, J., & Gaulard, P. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.01.002 · Cited by 79
Escribano, L., Órfão, A., Villarrubia, J., Dı́az-Agustı́n, B., Cerveró, C. J., Rios, A., Velasco, J. L., Ciudad, J., Navarro, J. L., & Miguel, J. F. S. (1998) · Analytical Cellular Pathology · doi:10.1155/1998/341340 · Cited by 77
Pascal, V., SCHLEINITZ, N., Brunet, C., Ravet, S., Bonnet, E., Lafarge, X., Touinssi, M., Reviron, D., Viallard, J., Viallard, J., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200425146 · Cited by 73
Paiva, B., Vídriales, M., Pérez, J. J., López‐Berges, M., García‐Sánz, R., Ocio, E. M., Heras, N. D. L., Cuello, R., de Coca, A. G., Pardal, E., et al. (2011) · Blood · doi:10.1182/blood-2010-12-324665 · Cited by 72
Cherian, S., Moore, J. S., Bantly, A. D., Vergilio, J., Klein, P. S., Luger, S. M., & Bagg, A. (2005) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20041 · Cited by 71
Minimal residual disease monitoring by flow cytometry
Vídriales, M., Miguel, J. F. S., Órfão, A., Coustan‐Smith, E., & Campana, D. (2003) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(03)00067-7 · Cited by 71
van de Loosdrecht, A. A., Ireland, R. M., Kern, W., Porta, M. G. D., Alhan, C., Balleisen, J. S., Bettelheim, P., Bowen, D., Burbury, K., Eidenschink, L., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.718341 · Cited by 71
Self-citationFlow-cytometric immunophenotyping of normal and malignant lymphocytes
Szczepański, T., van der Velden, V. H. J., & van Dongen, J. J. M. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.146 · Cited by 71
Self-citationFoucar, K. K. (2007) · American Journal of Clinical Pathology · doi:10.1309/k342-1w28-3805-633g · Cited by 70
Asnafi, V., Buzyn, A., Thomas, X., Huguet, F., Vey, N., Boiron, J.-M., Reman, O., Cayuela, J., Lhéritier, V., Vernant, J., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3666 · Cited by 69
Self-citationQuantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation
Menéndez, P. R., Vargas, A., Bueno, C., Barrena, S., Almeida, J., de Santiago, M., López, A., Roa, S., Miguel, J. F. S., & Orfao, A. (2004) · Leukemia · doi:10.1038/sj.leu.2403231 · Cited by 67
Self-citationPedreira, C. E., da Costa, E. S., Almeida, J., Fernández, C., Quijano, S., Flores-Montero, J. A., Bárrena, S., Lécrevisse, Q., van Dongen, J. J. M., & Orfao, A. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20638 · Cited by 65
Self-citationCannizzo, E., Bellio, E., Sohani, A. R., Hasserjian, R. P., Ferry, J. A., Dorn, M. E., Sadowski, C., Bucci, J. J., Carulli, G., & Preffer, F. I. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20517 · Cited by 65
Peripheral T‐cell lymphomas, unspecified (or not otherwise specified): a review
Rodríguez‐Abreu, D., Filho, V. B., & Zucca, E. (2007) · Hematological Oncology · doi:10.1002/hon.836 · Cited by 65
Geissinger, E., Sadler, P., Roth, S., Grieb, T., Puppe, B., Müller, N., Reimer, P., Vetter‐Kauczok, C. S., Wenzel, J., Bonzheim, I., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.021428 · Cited by 65
The Usefulness of CD26 in Flow Cytometric Analysis of Peripheral Blood in Sézary Syndrome
Kelemen, K., Guitart, J., Kuzel, T. M., Goolsby, C. L., & Peterson, L. C. (2007) · American Journal of Clinical Pathology · doi:10.1309/05gfg3ly3vycdmey · Cited by 65
Aberrant Underexpression of CD81 in Precursor B-Cell Acute Lymphoblastic Leukemia
Muzzafar, T., Medeiros, L. J., Wang, S. A., Brahmandam, A., Thomas, D. A., & Jorgensen, J. L. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp02rpvoktnwec · Cited by 65
Lima, M., Almeida, J., García‐Montero, A. C., Teixeira, M. D. A., Queirós, M. L., Santos, A. H., Balanzategui, A., Estevinho, A., Algueró, M. D. C., Bárcena, P., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63373-1 · Cited by 63
Self-citationAcute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification
van den Ancker, W., Terwijn, M., Westers, T. M., Merle, P. A., van Beckhoven, E., Dräger, A. M., Ossenkoppele, G. J., & van de Loosdrecht, A. A. (2010) · Leukemia · doi:10.1038/leu.2010.119 · Cited by 62
Molecular Characterization of a Novel Immune Receptor Restricted to the Monocytic Lineage
Aguilar, H., Álvarez‐Errico, D., García‐Montero, A. C., Órfão, A., Sayós, J., & López‐Botet, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6703 · Cited by 60
Lack of CD27 in myeloma delineates different presentation and outcome
Moreau, P., Robillard, N., Jégo, G., Pellat‐Deceunynck, C., Gouill, S. L., Thoumi, S., Avet‐Loiseau, H., Harousseau, J., & Bataille, R. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05849.x · Cited by 60
Hashimoto, M., Yamashita, Y., & Mori, N. (2002) · The Journal of Pathology · doi:10.1002/path.1126 · Cited by 55
Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias
Suggs, J. L., Cruse, J. M., & Lewis, R. E. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.08.012 · Cited by 55
Schernthaner, G.-H., Hauswirth, A. W., Baghestanian, M., Agis, H., Ghannadan, M., Worda, C., Krauth, M. T., Printz, D., Fritsch, G., Sperr, W. R., et al. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00865.x · Cited by 55
Kopp, P. A., Jaggi, R. B., Tobler, A., Borisch, B., Oestreicher, M., Sabacan, L. P., Jameson, J. L., & Fey, M. F. (1997) · Molecular and Cellular Probes · doi:10.1006/mcpr.1997.0099 · Cited by 51
Vašková, M., Mejstříková, E., Kalina, T., Martinková, P., Omelka, M., Trka, J., Starý, J., & Hrušák, O. (2005) · Leukemia · doi:10.1038/sj.leu.2403706 · Cited by 45
Self-citation‘Normal counterparts’ of nodal peripheral T‐cell lymphoma
Rüdiger, T., Geissinger, E., & Müller‐Hermelink, H. K. (2006) · Hematological Oncology · doi:10.1002/hon.786 · Cited by 44
Lima, M., Almeida, J., Teixeira, M. D. A., Queiros, M. L., Santos, A. H., Fonseca, S., Balanzategui, A., Justiça, B., & Órfão, A. (2003) · PubMed · Cited by 44
Self-citationAlmeida, J., Orfao, A., Mateo, G., Ocqueteau, M. E., García‐Sánz, R., Moro, M., Hernández, J.-M., Ortega, F., Borrego, D., Bárez, A., et al. (1999) · PubMed · Cited by 41
Self-citationLima, M., Teixeira, M. D. A., Fonseca, S., Gonçalves, C., Guerra, M., Queirós, M. L., Santos, A. H., Coutinho, A., Pinho, L., Marques, L., et al. (2000) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0342 · Cited by 39
CD30+ lymphoproliferative disorders
de Leval, L., & Gaulard, P. (2010) · Haematologica · doi:10.3324/haematol.2010.029256 · Cited by 37
Horan, P. K., Slezak, S. E., & Poste, G. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8361 · Cited by 36
Stetler‐Stevenson, M., Davis, B. H., Wood, B. L., et al. (2007) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20362 · Cited by 32
Boudewijns, M., van Dongen, J. J. M., & Langerak, A. W. (2007) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.060155 · Cited by 31
Self-citationNaeim, F., Rao, P. N., & Grody, W. W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-370607-2.00015-6 · Cited by 30
Bhargava, P., Kallakury, B., Ross, J. S., Azumi, N., & Bagg, A. (2007) · American Journal of Clinical Pathology · doi:10.1309/uxcdg9pwn7g89y54 · Cited by 29
Sugita, K., Mori, T., Yokota, S., Kuroki, M., O-Koyama, T., Inukai, T., Iijima, K., Goi, K., Tezuka, T., Kojika, S., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401408 · Cited by 29
Gattazzo, C., Teramo, A., Miorin, M., Scquizzato, E., Cabrelle, A., Balsamo, M. L., Agostini, C., Vendrame, E., Facco, M., Albergoni, M. P., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023358 · Cited by 28
Ravandi, F., Kantarjian, H. M., Jones, D. M., Dearden, C. E., Keating, M. J., & O'Brien, S. M. (2005) · Cancer · doi:10.1002/cncr.21405 · Cited by 28
CD45 expression in low-grade B-cell non-Hodgkin's lymphomas
Carulli, G., Cannizzo, E., Zucca, A., Buda, G., Orciuolo, E., Marini, A., & Petrini, M. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.06.002 · Cited by 27
Quijano, S., López, A., Rasillo, A., Bárrena, S., Sánchez, M. L., Flores-Montero, J. A., Fernández, C., Sayagués, J. M., Osuna, C. S., Fernández, N. S., et al. (2008) · Blood · doi:10.1182/blood-2007-10-119289 · Cited by 26
Self-citationPrognostic value of circulating CD34+ cells in myelodysplastic syndromes
Cesana, C., Klersy, C., Brando, B., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.03.028 · Cited by 22
Asnafi, V., Beldjord, K., Garand, R., Millien, C., Bahloul, M., Tutour, P. L., Douay, L., Valensi, F., & Macintyre, E. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403531 · Cited by 19
Self-citationImmunophenotyping parameters as prognostic factors in T-acute leukemia patients
Babušíková, O., Stevulová, L., & FAJTOVA, M. (2009) · Neoplasma · doi:10.4149/neo_2009_06_508 · Cited by 14
Rapid and simple immunophenotypic characterization of lymphocytes using a new test.
Bellido, M., Rubiol, E., Ubeda, J., Estivill, C., López, O., Manteiga, R., & Nomdedeu, J. F. (1998) · PubMed · Cited by 13
Immunophenotyping of acute leukemia: Utility of CD45 for blast cell identification
Vial, J., & Lacombe, F. (2001) · Methods in cell biology · doi:10.1016/s0091-679x(01)64021-4 · Cited by 11
DIAGNOSIS OF HAEMATOLOGICAL MALIGNANCIES: NEW APPLICATIONS FOR FLOW CYTOMETRY
Órfão, A., López, A., Flores-Montero, J. A., Vídriales, M., Pérez, J. J., Kneba, M., Macintyre, E. A., Parreira, A., Richards, S. J., & Trka, J. (2006) · Cited by 8
Self-citationEarly T-cell precursor acute lymphoblastic leukaemia
Taub, J. W. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70010-5 · Cited by 4
(2000) · PubMed
Cited by
Kumar, S., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M.-V., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30206-6 · Cited by 3,061
Self-citationSchuurhuis, G. J., Heuser, M., Freeman, S., Béné, M.-C., Buccisano, F., Cloos, J., Grimwade, D., Haferlach, T., Hills, R. K., Hourigan, C. S., et al. (2018) · Blood · doi:10.1182/blood-2017-09-801498 · Cited by 1,041
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Self-citationEuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., Kalina, T., Flores-Montero, J., van der Velden, V. H. J., Martin-Ayuso, M., Böttcher, S., Ritgen, M., Almeida, J., Lhermitte, L., Asnafi, V, et al. (2012) · Leukemia · doi:10.1038/leu.2012.122 · Cited by 783
Self-citationHeuser, M., Freeman, S. D., Ossenkoppele, G. J., Buccisano, F., Hourigan, C. S., Ngai, L. L., Tettero, J. M., Bachas, C., Baer, C., Béné, M.-C., et al. (2021) · Blood · doi:10.1182/blood.2021013626 · Cited by 763
Metadata
- Authors
- on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., Lucio, P., Mejstrikova, E., Szczepański, T., Kalina, T., de Tute, R., Brüggemann, M., Sedek, L., Cullen, M., Langerak, A. W., Mendonça, A., Macintyre, E., Martin-Ayuso, M., Hrusak, O., Vidriales, M. B., & Orfao, A.
- Venue
- Leukemia
- Published
- 2012-05-03
- Volume
- 26
- Issue
- 9
- Pages
- 1908-1975
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2090630520
- Cited by
- 934
- References
- 163
- FWCI
- 42.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.